Atrium Therapeutics, Inc. · NASDAQ:RNA
Gallagher Kathleen P. received 102,500 Atrium Therapeutics, Inc. shares as an award (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Gallagher Kathleen P. (Director, See Remarks) received 102,500 Atrium Therapeutics, Inc. shares as an award, leaving 131,361 shares. Filed Apr 22, 2026 (Form 4).
- Awarded
- 102,500 shares
- Holding after
- 131,361 shares
- Trading plan
- No
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Award | 102,500 | 131,361 | Direct |
Source
Related
- Atrium Therapeutics, Inc.
- Gallagher Kathleen P.
- Atrium Therapeutics, Inc. shareholders
- Form 4 · Gallagher Kathleen P. · Sep 22, 2026
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026